Risk of Congenital Ocular Anomaly After Prenatal Exposure to Medications: A <scp>EUROmediCAT</scp> Study

Erika-Alejandra Cifuentes(Inserm), Charlotte Dubucs(Centre Hospitalier Universitaire de Toulouse), Anke Rißmann(Otto-von-Guericke-Universität Magdeburg), Maria Loane(University of Ulster), Anna Latos Bieleńska(Medicina), Helen Dolk(University of Ulster), Christine Damase‐Michel(Inserm), David Tucker(UNSW Sydney), Hanitra Randrianaivo(Centre Hospitalier Universitaire de La Réunion), Isabelle Perthus(Centre Hospitalier Universitaire de Clermont-Ferrand), M Krawczyński(Poznan University of Medical Sciences), Luis Javier Echevarría González de Garibay(Basque Government), Ester Garne(University of Southern Denmark), Vera Nelen(Provincial Institute for Hygiene), Anna Pierini(Istituto di Fisiologia Clinica), Florence Rouget(Inserm), Babak Khoshnood(Inserm), Jorieke E. H. Bergman(University Medical Center Groningen), Mary O’Mahony(Health Service Executive), Sue Jordan(Swansea University), Ingeborg Barišić(University of Zagreb), Elisa Ballardini(University of Ferrara), Monique Courtade-Saïdi, Miriam Gatt(Ministry for Health), Anthony Caillet(Inserm), Félix Frémont, Nathalie Lelong(Inserm), Amanda J. Neville(University of Ferrara), M. C. Addor(Génétique Médicale & Génomique Fonctionelle), Anna‐Belle Beau(Inserm), Jonathan Hoareau, E. Den Hond(Provincial Institute for Hygiene)
Birth Defects Research
January 31, 2025
Cited by 2


Related Papers